Revatio
NDC Package 55154-2729-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Revatio is sildenafil is used to treat high blood pressure in the lungs (pulmonary hypertension). Marketed by Cardinal Health, this product is identified by NDC 55154-2729 and is authorized under FDA application NDA021845.

Identification & Billing

NDC Package Code
55154-2729-4
Package Description
90 POUCH in 1 CARTON / 1 TABLET, FILM COATED in 1 POUCH (55154-2729-6)
Product Code
55154-2729
11-Digit Billing Format
55154272904

Clinical Specifications

Proprietary Name
Revatio
Dosage Form
-
Usage Information
Sildenafil is used to treat high blood pressure in the lungs (pulmonary hypertension). It works by relaxing and widening the blood vessels in your lungs which allows the blood to flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. This medication is not recommended for use in children. Discuss the risks and benefits of this medication with the doctor.

Regulatory & Marketing

Labeler Name
Cardinal Health
FDA Application #
NDA021845
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-03-2005
End Marketing Date
08-31-2013
Listing Expiration
08-31-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55154-2729). Click a package code to view its specific billing and regulatory data.

55154-2729-0
10 POUCH in 1 BAG / 1 TABLET, FILM COATED in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-2729-4 identifies a specific commercial package of 90 pouch in 1 carton / 1 tablet, film coated in 1 pouch (55154-2729-6) of Revatio, labeled by Cardinal Health. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cardinal Health on June 03, 2005. The current certification is valid through August 31, 2013.

What are the primary indications for this medication?

Sildenafil is used to treat high blood pressure in the lungs (pulmonary hypertension). It works by relaxing and widening the blood vessels in your lungs which allows the blood to flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. This medication is not recommended for use in children. Discuss the risks and benefits of this medication with the doctor.

How is this Cardinal Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154272904. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-2729-4
11-Digit CMS (5-4-2)
55154-2729-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.